London, United Kingdom

Muthusamy Jayaraman

This inventor holds 1 USPTO granted patent and 6 published patent applications and 3 EPO patents. Top assignee: E-Therapeutics Plc. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Muthusamy Jayaraman. Retrieved from https://idiyas.com/inventor/muthusamy-jayaraman-n5sliisb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Muthusamy Jayaraman: Innovator in Therapeutic Oligonucleotide Compounds

Introduction

Muthusamy Jayaraman is a notable inventor based in London, GB. He has made significant contributions to the field of therapeutic oligonucleotide compounds. His work focuses on developing novel compounds that have the potential to treat various diseases and conditions.

Latest Patents

Muthusamy Jayaraman holds a patent for "Conjugated oligonucleotide compounds, methods of making and uses thereof." This invention relates to innovative conjugated oligonucleotide compounds that are suitable for therapeutic use. The patent also outlines methods for making these compounds and their applications in treating a range of diseases.

Career Highlights

Muthusamy Jayaraman is currently associated with E-Therapeutics Plc, where he continues to advance his research and development efforts. His work at the company emphasizes the importance of therapeutic innovations in the medical field.

Collaborations

Some of his notable coworkers include Ahmad Ali Mortazavi and Viviana Mannella. Their collaboration contributes to the innovative environment at E-Therapeutics Plc.

Conclusion

Muthusamy Jayaraman's contributions to the field of therapeutic oligonucleotide compounds highlight his role as a significant inventor. His patent and ongoing work at E-Therapeutics Plc demonstrate his commitment to advancing medical science through innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…